Showing 21 - 40 results of 326 for search 'Drugs in the United States', query time: 0.10s Refine Results
  1. 21

    Tobacco Use, Risk Perceptions, and Characteristics of Adults Who Used a Heated Tobacco Product (IQOS) in the United States: Cross-Sectional Survey Study by Hui G Cheng, Brendan Noggle, Andrea R Vansickel, Edward G Largo, Pierpaolo Magnani

    Published 2025-02-01
    “… BackgroundThe Tobacco Heating System (THS; commercialized as IQOS) is a smoke-free heated tobacco product introduced in the United States in 2019 and authorized by the US Food and Drug Administration as a modified risk tobacco product (MRTP) in 2020. …”
    Get full text
    Article
  2. 22

    Physicians' Desk Reference : PDR. / by Duffy, Marjorie A.

    Published 1991
    Subjects: “…Pharmaceutical Preparations / adverse effects / catalogs / United States…”
    View in OPAC
    Serial
  3. 23

    Therapeutic drug monitoring and neutralizing anti-drug antibody detection to optimize TNF-alpha inhibitor treatment for uveitis by Howard C. Chen, Jenny Shunyakova, Amit K. Reddy, Srujay Pandiri, Lynn Hassman

    Published 2025-01-01
    “…Here, we investigated the use of therapeutic drug monitoring and neutralizing anti-drug antibody detection as a strategy to optimize tumor necrosis factor (TNF)-alpha inhibitor treatment in patients who have a suboptimal response to the initial dosing of adalimumab.MethodRetrospective cohort study performed in two tertiary referral uveitis services in the United States between 2015 to 2023. …”
    Get full text
    Article
  4. 24
  5. 25

    Forensic Characteristics of Crimes in the Field of Trafficking in Narcotic Drugs, Psychotropic Substances, Their Analogues or Precursors by D. V. Golovin

    Published 2021-09-01
    “…Particular attention has been paid to the details of the person who uses drugs (a victim), the author has stated how personal danger is manifested for this category of people who use drugs. …”
    Get full text
    Article
  6. 26

    Cardiac and Systemic Thrombus Caused by Drug Abuse by John Eliveha, Shravani Vindhyal, Mohinder Vindhyal

    Published 2019-01-01
    “…Drug abuse is an increasing concern all over the world especially in the United States. …”
    Get full text
    Article
  7. 27
  8. 28
  9. 29
  10. 30

    Diphenhydramine as a Cause of Drug-Induced Liver Injury by Yunseok Namn, Yecheskel Schneider, Isabelle H. Cui, Arun Jesudian

    Published 2017-01-01
    “…Drug-induced liver injury (DILI) is the most common cause of acute liver failure in the Unites States and accounts for 10% of acute hepatitis cases. …”
    Get full text
    Article
  11. 31
  12. 32

    Drug Cost-Effectiveness Assessments Require Standards for Rigor and Inclusion by Tia Goss Sawhney, Neil Thakur

    Published 2023-02-01
    “…The Institute for Clinical and Economic Review (ICER), a nonprofit, nongovernmental organization, is the predominant independent price assessor in the United States. ICER’s cost effectiveness assessments are increasingly being used to support health insurance coverage and healthcare policy decisions. …”
    Get full text
    Article
  13. 33
  14. 34

    Should the Food and Drug Administration Limit Placebo-Controlled Trials? by Max Goodman, Connor Pedersen

    Published 2022-07-01
    “…However, the trial was deemed exploitative by a public watch group when it was revealed that the drug was already FDA-approved in the United States, and the manufacturer of that drug was undertaking another study with the same drug in Europe without any placebos. …”
    Get full text
    Article
  15. 35
  16. 36
  17. 37
  18. 38
  19. 39

    A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy by Robert Hodgson, Matthew Walton, Helen Fulbright, Laura Bojke, Ruth Walker, Alexis Llewellyn, Sofia Dias, Lesley Stewart, David Steel, John Lawrenson, Tunde Peto, Mark Simmonds

    Published 2025-01-01
    “…A limitation of most of the studies identified in the review is that they were conducted in the United States, making it challenging to apply their findings to the UK healthcare context. …”
    Get full text
    Article
  20. 40